UPMC Enterprises portfolio company Realyze Intelligence recently announced a collaboration with the Memorial Sloan Kettering Cancer Center (MSK) Innovation Hub. Through this partnership, the MSK Innovation Hub will use Realyze’s technology to pull unstructured data from patient charts to ultimately improve cancer treatment and care.”
Realyze uses AI technologies and deep-rooted clinical knowledge to enable health care organizations and vendors to have a better understanding of patients with cancer and chronic diseases. Its platform-as-a-service gives clinicians at hospital systems like MSK the tools they need to prescribe the most beneficial treatment options for their patients.
For Aaron Brauser, president and CEO of Realyze, this new partnership with MSK is a great representation of the services that Realyze provides.
“Our goal is to make it easy and efficient for health systems and cancer centers to understand and use all their data to improve patient care,” said Brauser. “By working with the MSK Innovation Hub, we have the opportunity to improve the care and quality of life for patients undergoing cancer treatments by ensuring their health care team has the most accurate and meaningful information.”
By collaborating with Realyze, MSK will be able to quickly extract and understand data that was previously trapped in patient records. This could have a positive impact on MSK’s research, clinical trial matching, cancer registry data curation, and a variety of options for cancer treatments.
Learn more by reading the press release and follow Realyze to stay up to date on the latest news.
